NCT04439539PegIFN-α2ahepatitis BJNJ-3989JNJ-73763989bersacapavirpegylated interferon-α2a
…antigen (HBsAg) and HBeAg.Objective The phase 2 REEF-IT study ( NCT04439539) assessed safety, efficacy and pharmacokinetics of pegylated in…
1articles mentioning institutions
1institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: NCT04439539 ×
NCT04439539
This institution is selected. Its supporting articles are shown below.